Find stats on top websites
VBI Vaccines is a biotechnology company focused on developing and commercializing vaccines. The company's leadership team has extensive experience in the pharmaceutical and biotechnology industries. Their expertise suggests a focus on vaccine research, development, and commercialization.
Company : VBI Vaccines
Industry : BiotechnologyPharmaceuticalsVaccines
VBI Vaccines Key Value propositions
VBI Vaccines Latest news
VBI Vaccines: Home
Skip to main content. Clinical Trials · Partnerships · Contact Us · News & Resources · Careers. Hit enter to search or ESC to close. Close Search. VBI Vaccines.
Valneva and VBI Vaccines Announce European Partnership for ...
Sep 8, 2022 ... Products Focusing on vaccines for infectious diseases with major unmet needs Learn More ... News and Resources: http://www.vbivaccines.com/news- ...
VBI Vaccines Announces Late-Breaking Poster Presentation at ...
Apr 9, 2019 ... Skip to main content. Clinical Trials · Partnerships · Contact Us · News ... vbivaccines.com. VBI Media Contact. Burns McClellan, Inc. Robert ...
Vaccine Manufacturers | Immunize.org
Jun 7, 2024 ... News & Updates. IZ Express NewsletterWeekly digest of important immunization news and updates. About IZ Express · Current Issue · Browse All ...
VBI Vaccines SWOT Analysis
Strengths
Experienced leadership team.Focus on innovative vaccine technologies.Strong R&D capabilities.
Weaknesses
Limited commercialized products.Dependence on funding and partnerships.Competition from larger pharmaceutical companies.
Opportunities
Growing demand for vaccines globally.Advancements in vaccine technology.Expansion into new vaccine markets.
Threats
Regulatory hurdles and approval processes.Potential for vaccine hesitancy.Rapid evolution of infectious diseases.
Top Marketing Strategies for VBI Vaccines
VBI Vaccines User Persona
Name:
Age :
Gender :
Occupation :
Industry :
Education :
Preferred platforms
GOALS
Frustrations
VBI Vaccines Geographic and Demographic Insights
Geographic Insights: The United States and Canada are the top two markets with a combined market share of 60%, likely due to VBI's operational presence and the high demand for vaccines in these regions.
United States
45%
Canada
15%
Germany
10%
United Kingdom
10%
Japan
5%
Demographic Insights: Target users span all age groups, with a slight preference towards older demographics (55+). Females slightly outnumber males, reflecting healthcare decision-making trends.
VBI Vaccines Socio-economic Profile
Household and Income Insights: The target audience primarily consists of individuals from middle-income households, with a significant portion from dual-income families (2-4 household size).
Educational and Employment Insights: A large percentage of the target users are likely to be highly educated professionals employed full-time, particularly in healthcare or related fields.
VBI Vaccines Behavioral Insights
Interest-Based Insights: Target users show a strong interest in biotechnology, pharmaceuticals, healthcare, medical research, infectious diseases, and vaccines.
Technology and Social Media Usage: Users primarily rely on professional platforms like LinkedIn and Twitter for information. While desktop usage is significant, there's also considerable engagement on YouTube.
VBI Vaccines Top Competitors
Competitor | Estimated market share | Top domains |
---|---|---|
Moderna | 35% | Biotechnology, Pharmaceuticals, Vaccines |
Pfizer | 30% | Pharmaceuticals, Vaccines, Healthcare |
Johnson & Johnson | 25% | Pharmaceuticals, Consumer Health, Medical Devices |